Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Neurogene (NGNE) Return on Capital Employed (2019 - 2025)

Historic Return on Capital Employed for Neurogene (NGNE) over the last 4 years, with Q3 2025 value amounting to 0.35%.

  • Neurogene's Return on Capital Employed rose 1400.0% to 0.35% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.35%, marking a year-over-year increase of 1400.0%. This contributed to the annual value of 0.31% for FY2024, which is N/A changed from last year.
  • Latest data reveals that Neurogene reported Return on Capital Employed of 0.35% as of Q3 2025, which was up 1400.0% from 0.33% recorded in Q2 2025.
  • In the past 5 years, Neurogene's Return on Capital Employed ranged from a high of 0.29% in Q1 2025 and a low of 1.02% during Q2 2023
  • In the last 3 years, Neurogene's Return on Capital Employed had a median value of 0.39% in 2024 and averaged 0.46%.
  • Its Return on Capital Employed has fluctuated over the past 5 years, first surged by 6300bps in 2024, then surged by 200bps in 2025.
  • Quarter analysis of 3 years shows Neurogene's Return on Capital Employed stood at 0.42% in 2023, then increased by 16bps to 0.35% in 2024, then rose by 0bps to 0.35% in 2025.
  • Its Return on Capital Employed was 0.35% in Q3 2025, compared to 0.33% in Q2 2025 and 0.29% in Q1 2025.